Zevra Therapeutics’ (ZVRA) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) in a research report report published on Thursday,Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Zevra Therapeutics’ Q1 2025 earnings at ($0.23) EPS, Q2 2025 earnings at ($0.08) EPS, […]
HC Wainwright reissued their buy rating on shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) in a research report report published on Thursday,Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Zevra Therapeutics’ Q1 2025 earnings at ($0.23) EPS, Q2 2025 earnings at ($0.08) EPS, […]
